Lisman Michael reported grant involving 30,908 derivative units of TransDigm Group INC at $0.00 for $0 on Nov 3, 2026

Grant
Form 4 code A. Grant, award, or other acquisition under Rule 16b-3(d).
President & CEO
President & CEO
Filed Nov 5, 2026

Facts from the filing

Form 4 · Derivative, table II
Disclosed value
$0Shares × reported price
Shares traded
30,908Stock Option
Price per share
$0.00Reported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
30,908Direct
Trade date
Nov 3, 2026Grant
Filed
Nov 5, 2026, 5:14 PM ET2-day reporting delay
Accession
0001748275-26-000001Code A · Transaction 393765
How reported position traded is calculated

Not calculated for derivative securities.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
Nov 3, 2026Grant4,214$0.00$0Trade 393762
Nov 3, 2026Grant1,053$0.00$0Trade 393763
Nov 3, 2026Grant18,923$0.00$0Trade 393764
Nov 3, 2026Grant4,189$0.00$0Trade 393766
5 transaction rows in this filing. Joint filers share the same rows.

TDG price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
TDG · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago −8.3%1w ago −5%1d ago +2.1%
Returns since7d +1.2%30d90d180d1y

Footnotes in full

F1: These options were granted in lieu of a cash bonus for Fiscal year 2026 in accordance with the Second Amended and Restated Employment Agreement, dated as of October 1, 2025, between TransDigm Group Incorporated and Michael Lisman, previously disclosed as Exhibit 10.1 to the Company's Form 8-K filed with the Securities and Exchange Commission on October 1, 2025 (the 'Employment Agreement'), and became exercisable on the grant date of November 3, 2026. F2: These options were granted in lieu of a cash bonus for Fiscal year 2026 in accordance with the Employment Agreement, and are eligible to vest on September 30, 2027, subject to the applicable vesting conditions. F3: These options were granted in accordance with the Employment Agreement and are exercisable at 20% per year over five years beginning September 30, 2027, subject to achievement of annual operating performance targets each year. F4: These options were granted in accordance with the Employment Agreement, and are exercisable in two equal installments on September 30, 2030, and September 30, 2031, subject to achievement of annual operating performance targets each year. F5: These options were granted in accordance with the Employment Agreement, and are exercisable at 80% in 2027 and 20% in 2028, subject to achievement of annual operating performance targets each year.